Global Mycoplasma Testing Market

Global Mycoplasma Testing Market Size, Share, Growth Analysis, By Application(Cell Line Testing, Virus Testing), By End-Use(Academic Research Institutes, Cell Banks) - Industry Forecast 2024-2031

Report ID: SQMIG35I2219 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 66 | Figures: 75

Global Mycoplasma Testing Market News

  • In February 2024, the PPD clinical research business of Thermo Fisher Scientific Inc. added mycoplasma and additional biosafety testing capabilities to its expanding portfolio of services at its good manufacturing practices (GMP) lab in Middleton, Wisconsin. 
  • In December 2023, QIAGEN N.V. announced the launch of three new kits for use on its QIAcuity systems and a major new software update. The new QIAcuity Mycoplasma Quant Kit offers researchers an accurate and precise way to detect mycoplasma contaminants in all steps of research and manufacturing of cell and gene therapies. 
  • In December 2021, Asahi Kasei Medical Co., Ltd. announced that it has (via a wholly owned subsidiary) fully acquired Bionique Testing Laboratories LLC (Bionique), a leader in mycoplasma testing services for the biotherapeutics and life-sciences industries.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Mycoplasma Testing Market size was valued at USD 298.91 Million in 2022 and is poised to grow from USD 340.76 Million in 2023 to USD 972.04 Million by 2031, at a CAGR of 14% during the forecast period (2024-2031).

The nature of the global mycoplasma testing market is highly competitive owing to the presence of several established players and new entrants. The market players are focusing on developing advanced technologies and solutions, expanding their product portfolios, and establishing strategic partnerships and collaborations to strengthen their position in the market. The Mycoplasma testing market is expected to continue to grow and evolve, driven by technological advancements, increasing demand for biopharmaceuticals and cell-based therapies, and stringent regulatory requirements. The market players are likely to continue to invest in R&D and innovation to develop more efficient, accurate, and cost-effective testing solutions to meet the growing demand from customers. 'Merck KGaA (Germany)', 'Thermo Fisher Scientific Inc. (US)', 'Lonza Group Ltd. (Switzerland)', 'Sartorius AG (Germany)', 'PromoCell GmbH (Germany)', 'American Type Culture Collection (ATCC) (US)', 'Agilent Technologies, Inc. (US)', 'Bionique Testing Laboratories, Inc. (US)', 'Biological Industries Israel Beit Haemek Ltd. (Israel)', 'Charles River Laboratories International, Inc. (US)', 'Creative Bioarray (US)', 'InvivoGen (US)', 'Minerva Biolabs GmbH (Germany)', 'Biological Industries US, Inc. (US)', 'Norgen Biotek Corp. (Canada)', 'Novacyt Group (UK)', 'Mycoplasma Experience (France)', 'Genscript Biotech Corporation (China)', 'GeneCopoeia, Inc. (US)', 'Jena Bioscience GmbH (Germany)'

The growing demand for biopharmaceuticals and cell-based therapies is driving the Mycoplasma testing market. These products and therapies require high-quality cells that are free from Mycoplasma contamination to ensure their safety and efficacy.

Development of advanced testing technologies and platforms: The Mycoplasma testing market is witnessing the development of advanced technologies and platforms, such as PCR-based assays, nucleic acid sequencing, and flow cytometry, that offer higher sensitivity, specificity, and speed compared to traditional culture-based methods.

In 2022, North America dominated the market and accounted for a revenue share of 40.0%. Due to the well-established healthcare sector in this business and the increased prevalence of respiratory illnesses, market share growth is predicted. The existence of multinational pharmaceutical and biotech corporations in the area, as well as increased investment in R&D operations, are other factors contributing to the growth of this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Mycoplasma Testing Market

Report ID: UCMIG35I2153 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Artemisinin Market
Buy Now GET FREE SAMPLE
Global Mycoplasma Testing Market

Report ID: SQMIG35I2089 | Region: Global | Published Date: April, 2024 | Pages: 242 | Tables: 89 | Figures: 66

Global Anti-Aging Market
Buy Now GET FREE SAMPLE
Global Mycoplasma Testing Market

Report ID: SQMIG35I2103 | Region: Global | Published Date: April, 2024 | Pages: 219 | Tables: 65 | Figures: 75

Global Cholera Vaccines Market
Buy Now GET FREE SAMPLE
Global Mycoplasma Testing Market

Report ID: SQMIG35I2229 | Region: Global | Published Date: April, 2024 | Pages: 157 | Tables: 115 | Figures: 77

Global Gummy Vitamins Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Mycoplasma Testing Market

Product ID: SQMIG35I2219

$5,300
BUY NOW GET FREE SAMPLE